The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular subtypes of clear cell renal cell carcinoma: Impact of diabetes mellitus, metformin, and immunotherapy on patient outcomes.
Scott Mattox Haake
No relevant relationships to disclose
Samira A Brooks
No relevant relationships to disclose
Eric Welsh
No relevant relationships to disclose
Anders Berglund
No relevant relationships to disclose
William J. Fulp
No relevant relationships to disclose
Dung-Tsa Chen
No relevant relationships to disclose
Eric B. Haura
No relevant relationships to disclose
Wade Jeffers Sexton
No relevant relationships to disclose
Philippe E. Spiess
No relevant relationships to disclose
Julio Pow-Sang
No relevant relationships to disclose
Kimryn Rathmell
No relevant relationships to disclose
Mayer N. Fishman
No relevant relationships to disclose